Monoclonal antibodies against claudin-18 for treatment of cancer
US-2024117022-A1 · Apr 11, 2024 · US
US9637548B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9637548-B2 |
| Application number | US-201013201726-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 18, 2010 |
| Priority date | Feb 20, 2009 |
| Publication date | May 2, 2017 |
| Grant date | May 2, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the identification of nucleic acid and amino acid sequences that are characteristic of colorectal, in particular colonic, and gastric tumor tissues and colorectal, in particular colonic, and gastric tissues, and which represent targets for therapy or diagnosis of such tumor diseases in a subject.
Opening claim text (preview).
The invention claimed is: 1. A method of detecting a tumor antigen peptide comprising the amino acid sequence of a tumor antigen encoded by a nucleic acid sequence of SEQ ID NO:1 in a patient, the method comprising obtaining a biological sample isolated from said patient, contacting said biological sample with an antibody which binds to amino acids 120-132 of SEQ ID NO:2 to form a detectable complex, and detecting whether said tumor antigen peptide is present in said sample by…
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.